Taking the lead in medical innovation.

Helping Kids Down the Path to Success: A Q&A with Representatives from the Boys & Girls Clubs of the Peninsula

Encouraging interest in STEM is one of our top goals at the Fogarty Institute. And that starts with offering opportunities, which is why Fogarty has partnered with the Boys & Girls Clubs of the Peninsula (BGCP) to show them the fields of medtech and entrepreneurship firsthand. For example, next summer, we will be offering the chance for BGCP college students to join the Lefteroff internship program.

Calumeo Aims to Make PPE Shortages a Thing of the Past With Practical Disinfecting Device

If there was one “most valuable player” that everyone in medical settings relied on during the pandemic, many would name personal protective equipment (PPE). However, while the lack of proper equipment has been felt acutely in every facility, the problem is not yet solved six months into COVID-19, with experts predicting that shortages could persist for years to come.

iDentical Raises $3.6 Million With its Novel Technology Designed to Address Dental Pain Point

COVID-19 might have temporarily closed dentist offices, but that hasn’t stopped iDentical from raising a healthy amount of cash for its innovative alternative to traditional dental implants.

Fogarty Institute company-in-residence iDentical has developed drill-free, non-invasive dental implants that leverage the latest 3D technology, with the goal of making tooth replacement safer,

Incubators Overcome Challenges, Point To Bright Future

If there’s one thing that incubators know how to do, it’s innovate. Therefore, it should come as no surprise that while the global pandemic provided challenges for everyone in every industry, incubators were able to find creative ways to survive and thrive.

A recent panel presentation brought together a number of speakers associated with all aspects of the incubator ecosystem,

Emme Prepares for Launch of New Device as an Elegant Solution to Prevalent Need

In these modern times, women who already juggle busy professional and personal lives – not to mention most caregiving responsibilities – often forget to take care of their own health.

Emme, which was co-founded by Ferolyn Fellow graduate Amanda French, is taking one thing off their plate —

Spirair Advances Office-Based Solution to Widespread Nasal Issue During Biodesign Summer Extension Program

Good ideas can come from anywhere, but as the Fogarty Institute has found over and over, the Stanford Biodesign Summer Extension program is a rich source for innovation. That’s why it has partnered with Stanford Biodesign to give promising projects even more hands-on expertise, including one-on-one and group mentoring, recommendations specialized to the company’s unique needs,

Fogarty Institute Helps Advance Promising Projects from Stanford Biodesign

For several years, the Fogarty Institute has partnered with Stanford Biodesign’s Summer Extension program, which provides funding to help advance promising projects. The Institute offers these young companies its signature hands-on mentoring from each member of the executive team, in addition to a dedicated mentor, along with a comprehensive development plan and opportunity to participate in educational workshops tailored to their specific needs.

Intrinsic Motivation a Key Trait for Successful Leadership

Success in leadership and entrepreneurship is often attributed to a balance of hard and soft skills. But there’s another factor that might be overlooked, and that’s the role that intrinsic motivation plays. In medtech, for example, we see company founders routinely ascribe their success to a deep desire to help patients, rather than just a drive for monetary gain.

Your Work Reimagined

Reimagining work will help lead us into a new chapter and beyond.

As some states begin to loosen their guidelines, many employees now will have the ability to move from shelter-in-place back to their offices. This remobilization has been referred to by many as “re-entry.”

But we will not be entering the same workspace in the same way;

Q&A with Denise Zarins, Fogarty Institute’s Chief Technical Officer

As we look ahead to the eventual easing of shelter-in-place requirements, companies are considering how to tackle the next phase of re-entry. Recently, we had the pleasure of hearing from Denise Zarins, Zach Edmonds, MD, and Gayle Kuokka, the dedicated re-entry leads for the Fogarty Institute, who held a collaborative discussion with our companies-in-residence and outside healthtech startups.

Are You Reaping the Full Benefits of Mentoring? Three Industry Leaders Share Insights

Most successful professionals will agree that if there is a “secret to success,” it’s having a mentor. And that holds true for the medtech profession as well, judging by the results of our Diversity by Doing (DxD) HealthTech survey. As noted in our recent report, both men and women who had a mentor reported significantly higher job satisfaction than those who didn’t.

Diversity by Doing Aims to Close the Gap on Gender Disparities in Healthtech

Diversity and inclusion have always been a goal of the Fogarty Institute, and over the past year we have been collaborating with the Stanford Byers Center for Biodesign and Maria Sainz, president and CEO of AEGEA Medical, on ways to achieve a more diverse representation within the healthtech field.

The team developed the Diversity by Doing (DxD) Healthtech initiative to identify and raise awareness of inequity,

A Message From Andrew Cleeland, CEO of the Fogarty Institute, on Diversity

“The struggle is always there. It gets discouraging sometimes. Some of us are trying to build a temple of peace. We speak out against war, we protest, but it seems that your head is going against a concrete wall. It seems to mean nothing. And so often as you set out to build the temple of peace you are left lonesome;

Spotlight: Pamela and Edward Taft, Philanthropists

Countless lives in the community and around the world have been touched by Pamela and Edward (Ed) Taft, who have made philanthropy the cornerstone of their daily lives. By generously contributing to causes they are passionate about in multiple broad areas—education, the environment and healthcare, to name three—they continue to make a lasting and profound impact.

Commercialization and Reimbursement are Topics of the Fogarty Institute’s First Virtual Workshop

To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.

This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,

Raydiant Oximetry Executive Team Spearheads the Launch of Ventilator Company Respirana

When Neil Ray, MD, founder and CEO of FII graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.

He first reached out to Russ DeLonzor,

Q&A with Mark Leahey, MDMA CEO and Fogarty Institute Board Member

As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,

UCSF-Stanford Pediatric Device Consortium Pitch Competition a Virtual Success

Innovation can’t be stopped by a quarantine. The 2020 annual UCSF-Stanford Pediatric Device Consortium Pitch Competition, originally scheduled to take place at the Stanford University School of Medicine, went off seamlessly in a virtual, but still highly interactive format last month.

The Pediatric Device Consortium (PDC) felt it was critical to hold the competition as planned in order to support the much-needed development of health technologies for children,

Q&A With Allan Will, Director, Fogarty Institute

When you’ve weathered adversity and come through on the other side, you bring a new perspective that can be helpful to those encountering a similar challenge for the first time. That’s why we turned to Allan Will for some advice based on his strong track record of founding, running, building and selling medical device companies,

New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market

Imagine having a really bad cold that never goes away—congestion, runny nose, facial pressure, headache and loss of smell for more than three months. That’s what it feels like to the more than 36 million people in the U.S. who suffer from chronic rhinosinusitis (CRS), a persistent inflammatory condition of the nasal and sinus cavity lining.

El Camino Health at the Forefront During COVID-19

While COVID-19 has presented extraordinary challenges globally, no one has felt it more acutely than those on the frontline, our incredibly brave healthcare workers. El Camino Health has been at the forefront of this crisis in an effort to stay ahead of the curve and prepare not only its own hospitals, but others in the area to best support Bay Area patients.

Spotlight: Fred St Goar, FII Vice Chairman of the Board

When he is not helping a patient, mentoring entrepreneurs at Stanford Biodesign, supporting the Fogarty Institute as a board member or assessing how to develop a new medical device, Fred St Goar, MD, is looking for ways to help improve the global health system. Through a lifetime of fascinating medical experiences, he is well-equipped to wear all those hats equally well.

Fundraising Workshop Generates Strong Interest Among Entrepreneurs and Medtech Community

It was a full house at the Fogarty Institute’s latest educational seminar titled “Fundraising – Art or Science?” highlighting the need and interest in this important topic. After all, it drives the future of all startups, but is particularly pertinent to early-stage companies immersed in finding appropriate funding.*

Attendees were also drawn to the breadth of experience of the speakers,

A $2 Million Grant From the National Cancer Institute A Highlight of a Noteworthy Year for EnSpectra Health

It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that will expedite the introduction of its groundbreaking skin cancer identification technology.

Bob Stahl on Finding Balance in Times of Uncertainty

As a society, we have found our lives upended as we adjust to new routines, including, for many of us, working from home while juggling caregiving and schooling. Add to that social distancing; although vital, it can contribute to people feeling disconnected while we are also emotionally drained, stressed and fearful. It’s easy to see that managing mental health is more important than ever.

Spotlight: Gordon Saul, Executive Director at Stanford Byers Center for Biodesign

When healthcare innovation drives you, the possibilities are endless. Like many successful healthtech entrepreneurs, Gordon Saul has worn many hats throughout his career, experiencing the industry from many different angles. Today, he is an integral part of an incredibly talented team as executive director at Stanford Byers Center for Biodesign, an organization that we are honored to have been partnering and collaborating with for many years.

Q&A with William (Bill) Starling, Co-Founder and CEO of Synecor; Managing Director of Synergy Life Science Partners

“My advice for you is to use your very best judgment in making life’s major decisions; follow your passion and your heart as you embark on life’s wonderful journey that lies ahead of you. Pursue your dreams until the day you die. Don’t take yourself too seriously and laugh every single day. Live your life ‘The Carolina Way,’ with hard work,

Madorra’s Device Sparks Overwhelming Interest

“We were given a gift to be able to solve a big problem, and though the road to getting a device to market is often a bumpy one, we have never lost our resolve to keep moving forward.”

That focus from Madorra, a Fogarty Institute graduate aiming to improve the quality of life for breast cancer survivors and post-menopausal women,

Fogarty Institute Hosts Innovator’s Reception at Prestigious J.P. Morgan Healthcare Conference

The growing size and influence of the much-anticipated 38th Annual J.P. Morgan Healthcare Conference continues to drive high attendance and concurrent events. This year, the Fogarty Institute played a larger role by hosting its first Innovator’s reception in partnership with Stanford Biodesign, The MedTech Strategist, RCT and the MedTech Innovator.

The reception was a success,

Spotlight: Marga Ortigas-Wedekind, FII Chief Commercial Strategy Officer

The Fogarty Institute continues to build its bench strength with the recent hire of seasoned medtech leader Marga Ortigas-Wedekind as chief commercial strategy officer. With 30 years of experience in medical and health technology companies at a variety of stages of development, her expertise will make her an asset to the entire team, most notably to our entrepreneurs,

Q&A with Ryan Schroeder, Director of the Taft Center for Clinical Research at El Camino Health

As a healthcare organization that is deeply invested in the well-being of its patients, El Camino Health has always strived to be at the forefront of innovation. Therefore, it is not surprising that it is also one of the few community hospitals that boasts a dedicated clinical research program. The effort started informally through the work of its physicians and has since evolved into a fully integrated part of the hospital operations as the Taft Center for Clinical Research.

“I Love What You Are Doing for Patients Just Like Me”

By Jon Coe, co-founder and CEO of Prescient Surgical, an FII graduate

Patients are the focus of everything we do in healthcare. Of course, it’s supposed to work that way, though at times, distractions, sheer system complexity and unintended or misaligned incentives can lead us astray. Healthcare innovation, in the broadest sense,

Fogarty Institute Proud of Increased Role in Successful 2019 Innovation Summit

With a goal of helping bring together investors and collaborators in the global medtech industry and shine a light on continuing education, the Fogarty Institute once again participated in the prestigious MedTech Strategist Innovation Summit San Francisco 2019 on November 18 and 19; this year assuming a larger role as a co-sponsor and co-organizer. As in the past,

Spotlight: Gary Kalbach, El Camino Hospital Board of Directors

One of Dr. Fogarty’s strengths when forming new companies was a focus on hiring experts in the field who had the ability to both embrace and expand on his vision. Such was the case when he asked Gary Kalbach to help him start the Fogarty Institute for Innovation in 2007. He became founding president and chair of the board,

Teamwork, Tenacity and the Value of a “Bet”

“I don’t believe in the concept of the ‘lone genius’ that journalists like to highlight when writing about the success of a company – it’s really the teams that win.”

This year’s 21stAnnual Thomas J. Fogarty, MD, Lecture held at Stanford University, featured Brook Byers, founding partner of Kleiner Perkins.

Voyant’s Smart Toilet Platform Addresses $13B Potential Market as it Simplifies Urine Sample Collection and Testing

Going to the doctor is not always a preferred activity, and part of that is the testing involved, including, of course, the ubiquitous urine test. This remains a standard method used to determine the proper course of treatment for patients and to prevent exposure to potentially harmful medications and procedures. Point-of-care urine tests are used to diagnose a range of conditions,

Q&A with Fletcher Wilson, Founder and CEO of InterVene

Entrepreneurship runs in Fletcher Wilson’s veins – quite literally. As founder and CEO of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of severe venous disease in the legs, Fletcher has many of the traits that make a successful leader and innovator. That includes a penchant for identifying problems and finding solutions,

Spotlight: Eric Chehab, Ph.D., Ferolyn Fellow

Seemingly intractable issues often have simple, elegant solutions when approached with creativity. That’s what Eric Chehab, Ph.D., has found in his work designing products that solve problems in neonatal care.

As the newest addition to the Ferolyn Fellowship class, he has already attained notable accomplishments in his young career, including co-founding and spearheading Novonate.

Q&A with Mike Mussallem, Chairman and CEO of Edwards Lifesciences

Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.

Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,

Raydiant Oximetry Raises Series A Funding; Graduates from Fogarty Institute

Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital. It follows on the heels of a recent string of funding rounds, grants and an exit by fellow Fogarty companies Enspectra

Institute’s Partnership with the FDA Enhances Relationships On Both Sides

Since its inception four years ago, the Fogarty Institute’s FDA Fellowship program has blossomed into a successful, ongoing partnership that is being lauded on both sides for enhancing the understanding, communication and collaboration between entrepreneurs and regulators. To date, the Institute has hosted 41 Fellows in addition to FDA scientists and department heads.

The relationship has proven to be beneficial for both sides: The FDA better understands the challenges inherent in device development,

Spotlight: Andy McGibbon, Ferolyn Fellow

From consulting to the Stanford Biodesign program, Andy McGibbon has had a front-row seat to how innovation can advance the healthcare field. And now he is delighted to join the Ferolyn Fellowship as a way to further explore the medtech ecosystem, thus enhancing his newest undertaking, Sonder Capital, a venture firm focused on early-stage medtech startups.

Q&A with Vincent Gaudiani, MD, Cardiac Surgeon at PCCSV

With more than 10,000 heart operations under his belt, Dr. Vincent Gaudiani is one of the most prolific practitioners in cardiovascular surgery. His early career followed a similar path as Dr. Fogarty’s, and the two later met at Stanford and have been colleagues and steadfast friends ever since.

Dr. Gaudiani received his bachelor’s degree in English from Harvard University,

EchoPixel Launches Intraoperative Device; Targets Structural Heart Disease

EchoPixel’s revolutionary technology is rapidly gaining adoption, having already been implemented by over 20 percent of the congenital heart defect programs in the U.S. and used extensively in complex, life-saving surgeries. It has played an essential role in several high-profile cases and has proven successful in both open surgery and interventional procedures.

Past Lefteroff Interns Thrive Post Program

The Lefteroff internship program, with its focus on mentorship and education, is a true reflection of the ideals of the Fogarty Institute. Each year, we are honored to host these bright young minds as they explore the potential for a career in the life sciences. The graduates represent an important legacy, which is why we are always keen to follow their progress.

Spotlight: Maria Artunduaga, MD, MPH, MTM, Ferolyn Fellow

When her beloved grandmother died from chronic obstructive pulmonary disease (COPD), a progressive lung condition that obstructs breathing, Maria Artunduaga, MD, MPH, MTM, realized it was an area that needed attention. That incident became a turning point in her training, leading her to the next phase of what has already been a highly accomplished career.

Q&A with Deborah Kilpatrick, Ph.D., CEO of Evidation Health; Ferolyn Fellowship Advisory Board Member

If you want a snapshot of Deborah (Deb) Kilpatrick’s storied career, you need look no further than the numerous accolades she has amassed. As just a sampling, she has been named on lists such as MM&M’s Top 40 Healthcare Transformers, FierceMedicalDevices’ Top Women in Medical Devices, Business Insider’s Most Powerful Women Engineers,

Sixth Annual Lefteroff Internship A Success With A Record 17 Participants

Building on a track record of great success, the sixth annual Lefteroff internship class was the biggest ever as the eight-week program keeps expanding and improving.

This year we had a broad range of interns hailing from around the country, China, India and Indonesia, with a variety of backgrounds and experiences.

iDentical Gives Patients and Dentists Something To Smile About With Drill-Free Dental Implants That are Lower Cost and More Accessible

Thanks to improved tooth-brushing habits, regular dental care and ubiquitous fluoridation, most Americans have benefited from better tooth health. And yet, many still lose their teeth, whether due to injury, decay or periodontal disease. In fact, studies find that approximately 178 million people in the United States are missing at least one tooth, and a surprising 40 million are missing all their teeth.

Panel Agrees IP Is Key To Earn Interest From VCs

Few seminar topics engage a startup audience as wholly as intellectual property, given that it’s viewed as one of the most critical components to success. Not only does it protect a company and allow it to compete among larger players, but it raises a startup’s profile among investors. In fact, 85 percent of medical device VCs say they view patents as a critical factor for funding consideration.

Spotlight: Rod Young, Former CEO of CyberHeart and Mentor

A seasoned medtech entrepreneur and executive, Rod Young has seen the industry from a variety of perspectives – as a division leader and eventually president of sizable companies; as an advisor and board member; and as an entrepreneur who founded, launched, took public and then sold medtech startups.

And as in the case with most luminaries in the industry,

Q&A with Casey McGlynn, Partner at Wilson Sonsini Goodrich & Rosati; Fogarty Institute Board Member

Training the next generation of medtech leaders is a topic of vital importance to the Fogarty Institute, given all our efforts in that direction. That’s why Andrew Cleeland was honored to be interviewed on that topic, along with Paul Yock, co-founder and director of the Stanford Biodesign program, at the opening dinner of the Wilson Sonsini Goodrich &

Chronus Health, FII’s Newest Company, Poised to Revolutionize $80 Billion U.S. Clinical Laboratory Testing Market

Imagine going to the doctor’s office for your annual check-up. The nurse starts going through the usual tests, such as measuring your blood pressure, heart rate and temperature and completing the blood draw from your arm.

Then the nurse immediately starts testing your blood with a hand-held device, explaining that instead of waiting for the sample to return from the lab,

Ferolyn Fellowship Builds On Its Fruitful Community of Mentors As It Welcomes A New Class

They say that the third time’s a charm, and the third class of Ferolyn Fellows proved that – not because of who was in the class – a stellar roster as always – but because of what we all have realized the program can be, says Liz McDermott, co-founder of the Ferolyn Fellowship.

Craig Straley Joins Fogarty Institute as Director of Clinical and Regulatory Affairs

As the Fogarty Institute continues to strengthen services to its companies-in-residence in areas critical to their growth and success, Craig Straley has joined as the director of clinical and regulatory affairs, bringing more than 20 years of experience in conducting clinical research with a number of successful startups.

From the Innovator’s Workbench: Jason Field, President and CEO, Shares How W. L. Gore & Associates Combines Innovation With Culture to Achieve Success

From rugged outwear to groundbreaking medical devices, W. L. Gore & Associates, a diversified material science company, serves virtually every industry you can think of.

That creativity of application can only be built by one thing – a focus on innovation.

Q&A With Jim Griffith, COO of El Camino Hospital

The Fogarty Institute has long enjoyed a reciprocal and collaborative relationship with El Camino Health, and over the years we have benefited from the expertise and mentoring of not only its physicians, but also its executive team.

Recently, Jim Griffith, who joined El Camino Hospital as chief operating officer in 2018,

Spotlight: James Wall, MD

A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,

palmm Wins Platinum in Shark Tank-Style Competition as It Eases the Suffering Caused by Excessive Sweating

From damp armpits to clammy palms, nearly one in 20 people in the U.S. suffers from hyperhidrosis. Also known as excessive sweating, this condition can significantly impair quality of life, confidence and emotional well-being as it limits activities, work and social relationships.

Spotlight: Mark Leahey, MDMA CEO and Fogarty Institute Board Member

Every industry needs a “voice” standing up for it, and the entrepreneurial sector of the medical device industry is fortunate to have Mark Leahey, president and CEO of the Medical Device Manufacturers Association (MDMA), as its advocate on Capitol Hill.

Mark has spearheaded MDMA since 2001, when the organization was just him,

Q&A with Thomas J. Fogarty, MD, FII Founder and Director

Given his impressive track record for inventions and the boundless energy he exhibits at the age of 85, no one would be surprised if Dr. Fogarty announced he had created his very own fountain of youth.

This passionate innovator never ceases to inspire and motivate us with the critical role he continues to play at the Fogarty Institute – checking in with the entrepreneurs on a daily basis as he brainstorms ideas and encourages them to keep looking for better pathways to solve critical problems,

Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough

Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif.

Funding success will serve several needs

“Fundraising has been one of our major focuses as we seek to take the startup to the next level,” said Gabriel Sanchez,

Building a Successful Roadmap to Commercialization – Recent Fogarty Institute Workshop Offers Insight on Taking Devices to Market

One of the most strategically important topics for a startup is commercialization – the point when a company transitions from research focus to generating revenue, scaling the organization, and potentially driving toward an exit. As part of its educational series, the Fogarty Institute recently hosted an impressive panel who offered their thoughts on managing this important phase of a company’s lifecycle.

Fogarty Institute Startups Make Strides; Raise Funds

It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to enhance patient care. That’s why we are delighted with recent advances in funding – while the funding environment can be challenging, the industry has demonstrated resilience and agility as startups seek to get innovative devices to market.

Spotlight: John Morriss, FII Director of Invention Acceleration Program

As the Fogarty Institute continues to expand the services it provides its partners and companies-in-residence, John Morriss, a seasoned medtech R&D professional, joins us as director of our Invention Acceleration program.

Q&A With Eb Bright, ExploraMed President and General Counsel

A patent attorney and inventor who also has extensive experience successfully founding companies, Earl ”Eb” Bright has been an invaluable player in advancing the medical technology industry.

In addition to his role as president and general counsel of ExploraMed, he has served on the executive team of many of its startup companies,

Tom Krummel, MD, Believes Continuous Learning Is at the Heart of a Successful Career

He almost needs no introduction, and yet, we would be remiss in not sharing a few of his finest traits: A contagious passion for our industry, an affinity for finding better solutions and an enthusiasm to share his insight and knowledge.

Q&A With Jeff Elkins, COO of InterVene

Jeff Elkins, a seasoned medtech executive with experience in both startups and larger companies, was recently hired as chief operating officer of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of venous disease in the legs.

Mobile Makerspace Concept for Hospitalized, Chronically Ill Patients Is Officially On the Move

What started as a vision to use a mobile makerspace as a tool to inspire young, chronically ill patients to learn, create and innovate – and help make lengthy hospital stays more palatable – is now becoming a reality, thanks to the generous support of Sheri Sobrato Brisson, a long-time supporter of seriously and chronically ill children,

J.P. Morgan Healthcare Conference Brings Opportunities As It Hosts a Who’s Who In the Life Sciences Industry

With luminaries such as Joe Biden, Bill Gates and Anne Wojcicki as keynote speakers, the J.P. Morgan Healthcare conference continues to be one of the most prominent events of its kind. This January, it was once again hosted in San Francisco, widely considered one of the meccas of the medtech industry.

Spotlight: Amanda French, Ferolyn Fellow

Unplanned pregnancies could someday be a thing of the past, thanks to EMME, a company started by Amanda French, one of the new Ferolyn Fellows.

As a child, she knew she wanted to be in healthcare, potentially as a doctor – she loved to help people and had a knack for science and math,

Q&A with Gregory Burns, Motivational Speaker, Artist, Author, Athlete

Every now and then you meet someone who deeply inspires you to strive to be the best individual and leader you can be – and who shows you the value and role of soft skills, like grit, creativity and communication, to not only survive the daily challenges we all face, but to thrive despite them.

Healyx Changes Lives by Treating Chronic Wounds

Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction.

Non-healing wounds are a critical global issue, with over eight million Medicare patients afflicted at an annual cost of $31.7 billion in the U.S.

Stanford Neurosurgeon and Entrepreneur Inspires Audience at 20th Annual Fogarty Lecture

This year’s annual Thomas J. Fogarty Lecture marked a milestone with the celebration of its 20thanniversary. The series, hosted by Stanford Biodesign and co-sponsored by the Fogarty Institute, started as a gathering to discuss and promote medical innovation with approximately 30 people in attendance. Since then, it has grown into a preeminent opportunity to learn from the most notable innovators in health technology.

Spotlight: Neil Zimmerman, Ferolyn Fellow

Neil Zimmerman came to the current class of Ferolyn Fellows with a good idea of how much he would learn and how it would benefit his career. That’s because he currently works as R&D engineering manager at Half Moon Medical, a company housed within The Foundry, where he works alongside Matt McLean,

Q&A with Kevin Longo, Northeast Head of Medical Device and Digital Health, Silicon Valley Bank

A banking partner who truly understands your industry and unique business challenges can make all the difference to a company’s success. And that’s what Silicon Valley Bank aims to do – in their words, “help innovators, enterprises and investors move bold ideas forward, fast.”

A key player in that ambitious agenda is Kevin Longo,

Alydia Health Raises $10M in Series B Financing; Company Aims to Eradicate PPH Globally

Fogarty Institute graduate Alydia Health, formerly known as InPress Technologies, is well on its way to conducting a pivotal study, thanks to the closing of a recent $10M Series B round led by Global Health Investment Fund. The U.S. study aims to prove the safety and efficacy of its novel device, the Jada System, in stopping postpartum hemorrhage (PPH) —

The Combination of High Touch and High Tech are Imperative: How Soft Skills Contribute to Leadership Success

Virtually every business talk or news story today emphasizes the revolutionary new technological advances that will transform the job landscape. And it’s true – technologies such as artificial intelligence, robots and digital platforms are already enhancing the way we work.

But often lost in the focus on these shiny new objects, is the need for workers to nimbly adapt to new environments,

Q&A With Holly Rockweiler, CEO and Co-Founder of Madorra

A former Stanford Biodesign Fellow and Fogarty Institute entrepreneur, 32-year-old Holly Rockweiler has already had remarkable accomplishments early in her career, fluently moving her startup to the next level.

Most notably, Holly has parlayed Madorra’s impressive study results into securing funding, including winning several pitching competitions, despite the chronically challenging medtech fundraising environment.

Spotlight: Ridhi Tariyal, Ferolyn Fellow

Each year, the caliber of professionals who participate in the Ferolyn Fellowship continues to impress us. Hailing from diverse parts of the healthcare spectrum, they all share an undeniable passion for the medtech industry, coupled with curiosity and the tenacity to solve large problems. In addition, it’s clear that they desire to be part of a community committed to not only accelerating their own career path,

InterVene Makes Strides in Venous Interventional Space

Fogarty Institute graduate InterVene, a startup that has developed a minimally invasive device for the treatment of venous disease in the legs, has treated the 10th patient in their ongoing, multi-center, feasibility study in New Zealand and Australia.

Ferolyn Fellowship Welcomes New Class; Showcases Benefits of “Connecting Bright Minds”

Learning to build a healthy company culture; becoming an empathetic, yet effective, leader; and giving back to individuals and the industry are just a few of the important skill sets learned by the Ferolyn Fellows. They are also key traits embodied by the program’s namesake, Ferolyn Powell.

New Fogarty Institute Company Lume Medical Developing a Large Bore Vascular Closure Device, a Key Benefit to Cardio Patients

When a cardiovascular intervention is called for, a less-invasive solution is always preferred – which is why percutaneous procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) are on the rise.

But this trend hasn’t been without its drawbacks, as cardiologists and surgeons are now faced with the challenge of closing relatively large femoral access sites – ranging from three to eight millimeters in size – that are required to conduct these procedures.

Spotlight: Gayle Kuokka, Fogarty Institute CFO

The Fogarty Institute prides itself on hiring staff members who are as innovative and impressive as its companies-in-residence. That means that not only must they have the skill sets for the specific job, but they also come with a well-rounded background and passion for the industry and the startup environment, thus allowing them to inspire our colleagues and mentor our entrepreneurs.

Q&A with Lewis Wexler, MD, Fogarty Institute Board Member

The strength of a board comes from the diverse experiences of its members, their passion for the mission and their ability to provide sage advice. Lewis (Lew) Wexler, MD, one of the Fogarty Institute’s inaugural members, joined the board as the organization’s mission and structure were still being formed and over the years has been a staunch ally and supporter of its educational approach.

A Summer to Remember: Lefteroff Interns Gain Valuable Insight Into the Medtech Industry and Career Best Practices

There’s nothing more inspiring than working with interns and feeding off their curiosity and eagerness to learn more about the life sciences industry. That’s why the Lefteroff Fellowship remains one of our favorite programs here at the Institute.

Now in its fifth year, it continues to evolve, thanks to our expanding collaboration with El Camino Hospital physicians,

Spotlight: Anura Patil, Ferolyn Fellow

Throughout her career, Ferolyn Fellow Anura Patil has sought to solve large problems that deeply impact people’s lives, by addressing the technical and commercial challenges that are bound to arise. An advocate of diverse and cross-functional teams, she has also focused on developing strong communities of women at her workplace and school. Today she is bringing that passion and skillset to Tueo Health as COO,

Q&A with Casey McGlynn, Partner at Wilson Sonsini Goodrich & Rosati; Fogarty Institute Board Member

Casey McGlynn’s roots in the medical device industry go back over 40 years. During much of that period he has had the good fortune to observe and work with Tom Fogarty as a surgeon, inventor, company founder, investor and board member. Today Casey is a board member at the Fogarty Institute and a partner of Wilson Sonsini Goodrich &

EchoPixel Poised to Revolutionize the Operating Room of the Future

Among the hottest topics in healthcare is the “operating room of the future,” which is on the brink of transformation as new technologies such as artificial intelligence (AI), voice recognition, digital technology and augmented reality are integrated.

And at the forefront is EchoPixel, a Fogarty Institute graduate that has created an interactive,

Inside Tips on IP: What Entrepreneurs Need to Know

“Innovation is a discipline that can be both taught and honed,” is one of the mottos behind the Fogarty Institute educational workshop series. These sessions are designed to inspire both early-stage and seasoned entrepreneurs, but also give them insight into the best practices that will help them succeed as they take their ventures to the next level.

Gokul Krishnan Visits Fogarty Institute to Share His Vision of Using Makerspaces to Inspire Young Patients to Learn, Create and Innovate

Imagine a setting where young patients confined to hospital rooms for weeks at a time have the opportunity to invent and build anything their mind can imagine. That’s the environment that Gokul Krishnan, Ph.D., set out to create when he launched “Maker Therapy,” an initiative born from his Ph.D. research at Vanderbilt University’s Peabody College of Education.

Spotlight: Corinne Landphere, Fogarty Institute Coach and Team Building Advisor

As an entrepreneur, mentor, artist, philanthropist and mother of two, Corinne Landphere leads a full and varied life – and has throughout her prolific career in healthcare. This rich background led to the successful launch of Corinne Landphere Consulting, where she has helped numerous companies build successful organizations by focusing on team building,

Q&A with David Cassak, Managing Partner of Innovation in MedTech, LLC

A long-time friend of Tom Fogarty, the Fogarty Institute and the medtech industry, David Cassak is one of the industry’s most well-respected experts, immersed in all aspects as managing partner of Innovation in MedTech, LLC, the publisher of the MedTech Strategist, where he is co-editor-in-chief. He is a frequent speaker at industry events,

A Better Kind of “Gut Check”

Often referred to as the “second brain,” the gut is garnering increased attention as mounting evidence shows the key role it plays far beyond digesting food in influencing our moods and general health. G-Tech Medical, a Fogarty Institute company, is playing a critical role in helping to better understand the complexities of our gut and its 500 million neurons.

Spotlight: Tom Krummel, MD, Fogarty Institute Chairman of the Board

Tom Krummel is one of those rare individuals who has seen and experienced medical innovation from every front, including stints as an academic, surgeon, writer, mentor and administrator. He continues to impact the medtech field and patient care as chairman of the Fogarty Institute and co-director of Stanford Biodesign.

Q&A with Dan Woods, CEO of El Camino Hospital

We have been looking forward to sitting down with the new CEO of long-time Fogarty Institute partner El Camino Hospital, which provides a forum where innovators can work directly with experienced, recognized physicians and conduct clinical trials, as four companies-in-residence currently are doing. Dan Woods joined the hospital in the fall of 2017, bringing an entrepreneurial spirit,

nVision’s Acquisition Positions Innovative Technology to Potentially Help Millions of Women

As the first and only device cleared by the FDA to collect cells from the fallopian tubes, the Mako 7 device, originally developed by nVision, a Fogarty Institute graduate, offers a potential platform for earlier detection of ovarian cancer. The company was recently acquired by Boston Scientific, as the device represents an exciting opportunity for the company to expand its focus on women’s health and provides a potential platform to improve care for women worldwide.

The One Clear Message from the FDA? “We are Here to Help”

Navigating through the Food and Drug Administration’s (FDA) policies, laws, pathways to approval and potential changes to existing regulations can be an intimidating process, especially for new or early-stage medical device startups. However, the organization has done an admirable job at proactively developing educational programs and reaching out to the industry and consumers.

Q&A with Mark Leahey, CEO of the Medical Device Manufacturers Association 

As any successful medtech company knows, developing an innovative device is just the first step in improving patient care. Once that idea has come to fruition, regulatory approval begins, which is why medtech startups need an ally who can help walk them through the process and be their voice with the regulatory bodies who will ultimately grant approval and reimbursement,

Rep. Khanna Shares His Views on Technology and Education as Keys to Continued American Success

“A truly prosperous American economy is one that is diversified, driven by innovation and works for all people. I believe that to achieve this across the country, we must embrace technology and use it as a vehicle to put people to work. I support advanced American manufacturing, as well as a nationwide investment in high-tech apprenticeships and worker training programs.”

Prescient’s CleanCision Helps Prevent Surgical Site Infections With Revolutionary Active Cleansing Technology

Prescient’s CleanCision has been shown to reduce Surgical Site Infection risk by 61 percent.

Spotlight: K. Angela Macfarlane, Institute Board Member; Founder, Managing Member and CEO of ForSight Labs, LLC

Angela Macfarlane Brings Decades of Medtech Experience and Mentoring Acumen to Fogarty Institute Board

Some people’s careers are a straight path, while others are a winding road. The latter was the case for Angela Macfarlane. After all, not many people can say they started their career in the field of law as a judicial extern for the United States District Court,

Japan Biodesign Fellows from Osaka, Tokyo, and Tohuko Universities visited the Fogarty Institute

Japan Biodesign and Other Organizations from Around the Country and the World Visit the Institute to Learn about Innovation and Entrepreneurship

Nihon Kohden Innovation Center Chooses Fogarty Institute as Entrepreneurial Partner

Nihon Kohden, the leading developer, manufacturer and distributor of medical electronic equipment, has had an illustrious history in innovation since its inception in 1951,

Q&A with Zachary Edmonds, MD, Palo Alto Medical Foundation Hospitalist; Fogarty Institute Mentor

Zach Edmonds shares his view on the intersection between medical practice and innovation

On the surface, you may not realize how many traits clinicians and entrepreneurs share, but Zachary (Zach) Edmonds, MD, has been able to successfully pursue both fields. While he was intrigued by the human body and its ability to heal and adapt

Monthly Spotlight: Elizabeth McDermott, Founder, Ferolyn Fellowship

Unconditional passion for the industry. A patient-first mindset. Grit. A selfless willingness to give back to the field to help advance the next generation of entrepreneurs and inventors.

These are just a few of the traits that describe the individuals drawn to the medical device industry, and one of the aspects that makes it so unique and strong.

A Special “Workbench” Session Honors Medtech Innovation’s Past and Present

A Special “Workbench” Session Honors Medtech Innovation’s Past and Present

When you think of medtech innovation, there are few individuals who were as influential and inspiring as Tracy Lefteroff, which was why it was so fitting that the recent Stanford Biodesign “From the Innovator’s Workbench” honored his legacy.

Zebra Medical Technologies’ Device Provides an Answer to Deluge of Skin Cancer Screenings

Zebra Medical Technologies’ Device Provides an Answer to Deluge of Skin Cancer Screenings

American dermatologists experienced 7.5 million office visits for suspected non-melanoma skin cancer in 2017, and a number of factors are indicating these numbers are liable to increase.

Dr. Fogarty Continues His Legacy at Age 84, With No Signs of Slowing Down

With age, comes wisdom, and although no one who knows Dr. Fogarty would call him “old,” there’s no doubt his wisdom benefits us all.

Dr. Fogarty, who celebrated his 84th birthday on February 25, is an inspiration to us all. Most of us know his many accomplishments, but for those who don’t, he is one of the most notable cardiovascular surgeons and innovators of all time and recipient of the prestigious Presidential National Medal of Technology and Innovation,

Mike Regan Joins the Fogarty Institute as Chief Innovation Officer

As the Fogarty Institute continues to expand and strengthen its services and broaden its relationships, it has hired medtech industry professional Michael (Mike) Regan as chief innovation officer.

Mike comes to the Institute with 35 years of industry experience, spanning a broad range of positions in general management, product development, operations, sales and marketing,

Fogarty Institute Closes Prestigious MedTech Strategist Innovation Summit 2017

Industry conferences seem to bring out the best in participants as different entities come together to support and learn from one another. The close-knit medtech ecosystem is no exception, as entrepreneurs and industry leaders attended the recent MedTech Strategist Innovation Summit in San Francisco, united in their mission to advance patient care.

A 38-year-old patient immediately after being treated with CyberHeart’s technology

CyberHeart, a startup that is developing the world’s first non-invasive treatment for cardiac arrhythmias, has experienced tremendous clinical successes in the past few months.

“This is a game changer,” (for patients with irregular heart rhythm), said Dr. Melvin Scheinman, a professor of medicine at the University of California, San Francisco, and past president of the Heart Rhythm Society,

Monthly Spotlight: Shreya Mehta, Ferolyn Fellow

Like many successful medtech entrepreneurs and Ferolyn Fellows, Shreya Mehta has a passion and knack for building and finding solutions to challenging and unsolved problems — skills which led her to co-found and launch Zenflow.

Monthly Spotlight: Stacy Enxing Seng

At the Fogarty Institute we depend on our board of seasoned professionals to help us continue to grow and adapt to the medtech market. That’s why we were delighted to add another elite name to our esteemed group, with Stacy Enxing Seng joining as our newest member. With nearly 30 years of experience in the medtech industry,

Clinical Evidence and Health Economics

Seminar Reviews the Importance of Clinical Evidence and Health Economics in Getting to Market

Many medical device entrepreneurs believe that the single most important milestone to achieve in gaining market adoption of their technology is regulatory approval. While certainly an essential step, it is often not sufficient.

Julia Fox, Ferolyn Fellow

At the onset of her studies at Johns Hopkins University as a Biomedical Engineering student, Julia Fox knew she wanted her career path to be one that would make an impact on health and healthcare.

That devotion underscores a number of career moves she has made along the way, eventually bringing her to the Fogarty Institute as a Ferolyn Fellow,

EchoPixel’s technology plays critical role in success of conjoined twins surgery

“There is a better way” is a common mantra heard frequently in discussions between Fogarty Institute mentors and its entrepreneurs. It’s what drives us each day to devise and create new technologies that will transform patient care. And while the process is not always easy, there is nothing more rewarding than seeing a successful patient outcome as a result of a device that was created right here,

Spotlight: Matt McLean, Ferolyn Fellow

Knowledgeable, articulate and already on a solid career path, it’s easy to understand why Matt McLean, senior engineering manager at Medtronic, was selected to be part of the first group of Ferolyn Fund fellows.

The benefits of working in medtech are unmatched: When you are successful, you realize you have developed something that will save a patient or relieve pain and suffering.

— Dr. Thomas J. Fogarty